Facebook
X
LinkedIn
Forward
Cancer Therapies for APPs: A Comprehensive Review (On-Demand) 2026
Overview
Over the past several decades, cancer therapy has evolved from conventional chemotherapy to targeted agents, immunotherapy, and other novel approaches. To help APPs and other clinicians navigate how these therapies are used to treat solid tumors and hematologic malignancies, Horizon CME has developed “2026 Cancer Therapies for APPs: A Comprehensive Review”. In this virtual two-day program, clinicians will gain understanding of the various classes of cancer therapy, their mechanisms of action, safety profiles, and applicability in hematologic malignancies and solid tumors. Participation in this program will provide APPs with the practical knowledge they need to provide support and care for patients with cancer.
Learning Objectives
Target Audience
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.
Course summary
- 12.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Enduring activity for a maximum of 12.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 12.00 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.
- 11.75 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 11.75 credit.
Available Credit
- 12.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Enduring activity for a maximum of 12.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 12.00 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 12.00 credit.
- 11.75 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 11.75 credit.
Price
Required Hardware/software
Access to the internet is required.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above